Turk Ilac ve Serum Sanayi AS (TRILC) — Cash Flow Reinvestment Rate
Turk Ilac ve Serum Sanayi AS (TRILC) has a Cash Flow Reinvestment Rate of 4.39x as of September 2025, reinvesting TL195.46 Million (capex TL142.42 Million plus investments TL-53.05 Million) from operating cash flow of TL44.50 Million. See TRILC free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Turk Ilac ve Serum Sanayi AS Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for Turk Ilac ve Serum Sanayi AS across 4 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Turk Ilac ve Serum Sanayi AS.
Annual Cash Flow Reinvestment Rate for Turk Ilac ve Serum Sanayi AS (2018–2023)
Year-by-year capital reinvestment analysis for Turk Ilac ve Serum Sanayi AS. See financial flexibility index of Turk Ilac ve Serum Sanayi AS to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TRY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.56x | TL230.62 Million | TL408.19 Million | TL115.31 Million | ▼ -39.8% |
| 2020 | 0.94x | TL31.14 Million | TL33.20 Million | TL16.54 Million | ▼ -73.7% |
| 2019 | 3.56x | TL47.45 Million | TL13.32 Million | TL24.92 Million | ▲ +927.5% |
| 2018 | 0.35x | TL13.22 Million | TL38.13 Million | TL0.00 | — |